One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Semler Scientific just hit that mark, with a jump from 79 to 89 Tuesday.
IBD's proprietary RS Rating identifies technical performance by showing how a stock's price action over the last 52 weeks measures up against that of the other stocks in our database.
History reveals that the market's biggest winners tend to have an 80 or higher RS Rating in the early stages of their moves.
Hone Your Stock-Picking Skills By Focusing On These Factors
Semler Scientific has climbed more than 5% past a 29.93 entry in a first-stage cup with handle, meaning it's now out of a proper buy zone. Look for the stock to create a new buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.
Taking a look at revenue and profit performance, the company has posted rising EPS growth in each of the last two reports. Revenue gains have been a different story, coming in at -18% in the most recent quarterly report.
The company earns the No. 22 rank among its peers in the Medical-Products industry group. Boston Scientific, Pro-Dex and Penumbra are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
